0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

high cost case management concerns misleading

22 February 2013

Media stories suggesting high-cost cases are to escape new management rules do not depict a true picture.

Costs management is a crucial part of the Jackson reforms. It is suggested that the civil procedure rules will not apply to commercial cases worth more than £2 million and will be exempt from costs management.

The costs Budgeting Direction amending the new CPR 3.12(1) issued by the President of the Queens Bench Division Sir John Thomas, notes that cost management will be used in all cases except where there is good reason not do so.

Although headlines may suggest otherwise, it is likely that costs management will be the norm post-April and should always be considered, even when exceptions are carved out. Anyone who thinks differently may be in for a shock.

related opinions

World Patient Safety Day - health worker safety: a priority for patient safety

The theme for this year’s World Patient Safety Day is “Health Worker Safety: A priority for Patient Safety” and whilst there are many different aspects to this in terms of both physical and psychological safety is vital to promote learning and improve patient safety.

View blog

Covid-19: New guidance for small scale manufacturers of PPE

The Office for Product Safety & Standards has just released its new guidance for small scale suppliers of PPE.

View blog

AI: support for buying new technology

The world of healthtech and digitech is continuing to develop at pace and as a result of Covid-19 we are seeing it being used and implemented to a greater extent across the NHS and wider health and care market.

View blog

Internal Market Bill published today – the start of the controversy?

The Internal Market Bill is published today, but amid much controversy.

View blog

mailing list sign up



Select which mailings you would like to receive from us.

Sign up